Complications at the End of Life in Ovarian Cancer

Lisa J. Herrinton, Christine Neslund-Dudas, Sharon J. Rolnick, Mark C. Hornbrook, Donald J. Bachman, Jeanne A. Darbinian, Jody M. Jackson, Steven Scott Coughlin

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Women dying of ovarian cancer vary considerably in their complications and in the types of health care they receive. The objective of this study was to describe the complications of ovarian cancer, other than pain, and their treatment at the end of life. This study used a cohort of 421 enrollees in three nonprofit managed-care organizations who died with ovarian cancer during 1995-2000. Data were collected from abstraction of paper and electronic medical records. Proportions of women experiencing complications and undergoing treatments were calculated. Logistic regression was used to evaluate the association of patient characteristics with the probability of receiving an intervention for complications. The most common complications recorded in the medical record were fatigue or weakness (75%), nausea or vomiting (71%), constipation (49%), edema of the extremities (44%), and anemia (34%). The prevalence of major complications was as follows: ascites, 28%; bowel obstruction, 12%; pleural effusion, 10%; bladder obstruction, 3%; and disordered nutrition that required support with parenteral nutrition, 9%. Patients may not always have received interventions for major complications; for example, pleural effusion apparently was left untreated in almost half of the women with this problem. After adjustment, women who died at younger ages were more likely to receive an intervention, compared to older women (odds ratio for each decade of age, 0.71, 95% confidence interval = 0.53, 0.94, P for trend = 0.02). The study, which preceded the establishment of palliative care programs, suggests that care given to ovarian cancer patients at the end of life may be inadequate.

Original languageEnglish (US)
Pages (from-to)237-243
Number of pages7
JournalJournal of Pain and Symptom Management
Volume34
Issue number3
DOIs
StatePublished - Sep 1 2007
Externally publishedYes

Fingerprint

Ovarian Neoplasms
Pleural Effusion
Electronic Health Records
Parenteral Nutrition
Managed Care Programs
Constipation
Palliative Care
Ascites
Nausea
Vomiting
Medical Records
Fatigue
Anemia
Edema
Urinary Bladder
Extremities
Logistic Models
Odds Ratio
Organizations
Confidence Intervals

Keywords

  • cohort study
  • complications
  • death
  • electronic medical records
  • end of life
  • medical record abstraction
  • Ovarian cancer

ASJC Scopus subject areas

  • Nursing(all)
  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Cite this

Herrinton, L. J., Neslund-Dudas, C., Rolnick, S. J., Hornbrook, M. C., Bachman, D. J., Darbinian, J. A., ... Coughlin, S. S. (2007). Complications at the End of Life in Ovarian Cancer. Journal of Pain and Symptom Management, 34(3), 237-243. https://doi.org/10.1016/j.jpainsymman.2006.11.011

Complications at the End of Life in Ovarian Cancer. / Herrinton, Lisa J.; Neslund-Dudas, Christine; Rolnick, Sharon J.; Hornbrook, Mark C.; Bachman, Donald J.; Darbinian, Jeanne A.; Jackson, Jody M.; Coughlin, Steven Scott.

In: Journal of Pain and Symptom Management, Vol. 34, No. 3, 01.09.2007, p. 237-243.

Research output: Contribution to journalArticle

Herrinton, LJ, Neslund-Dudas, C, Rolnick, SJ, Hornbrook, MC, Bachman, DJ, Darbinian, JA, Jackson, JM & Coughlin, SS 2007, 'Complications at the End of Life in Ovarian Cancer', Journal of Pain and Symptom Management, vol. 34, no. 3, pp. 237-243. https://doi.org/10.1016/j.jpainsymman.2006.11.011
Herrinton LJ, Neslund-Dudas C, Rolnick SJ, Hornbrook MC, Bachman DJ, Darbinian JA et al. Complications at the End of Life in Ovarian Cancer. Journal of Pain and Symptom Management. 2007 Sep 1;34(3):237-243. https://doi.org/10.1016/j.jpainsymman.2006.11.011
Herrinton, Lisa J. ; Neslund-Dudas, Christine ; Rolnick, Sharon J. ; Hornbrook, Mark C. ; Bachman, Donald J. ; Darbinian, Jeanne A. ; Jackson, Jody M. ; Coughlin, Steven Scott. / Complications at the End of Life in Ovarian Cancer. In: Journal of Pain and Symptom Management. 2007 ; Vol. 34, No. 3. pp. 237-243.
@article{66635c59687a413b91c95c0ef7affa82,
title = "Complications at the End of Life in Ovarian Cancer",
abstract = "Women dying of ovarian cancer vary considerably in their complications and in the types of health care they receive. The objective of this study was to describe the complications of ovarian cancer, other than pain, and their treatment at the end of life. This study used a cohort of 421 enrollees in three nonprofit managed-care organizations who died with ovarian cancer during 1995-2000. Data were collected from abstraction of paper and electronic medical records. Proportions of women experiencing complications and undergoing treatments were calculated. Logistic regression was used to evaluate the association of patient characteristics with the probability of receiving an intervention for complications. The most common complications recorded in the medical record were fatigue or weakness (75{\%}), nausea or vomiting (71{\%}), constipation (49{\%}), edema of the extremities (44{\%}), and anemia (34{\%}). The prevalence of major complications was as follows: ascites, 28{\%}; bowel obstruction, 12{\%}; pleural effusion, 10{\%}; bladder obstruction, 3{\%}; and disordered nutrition that required support with parenteral nutrition, 9{\%}. Patients may not always have received interventions for major complications; for example, pleural effusion apparently was left untreated in almost half of the women with this problem. After adjustment, women who died at younger ages were more likely to receive an intervention, compared to older women (odds ratio for each decade of age, 0.71, 95{\%} confidence interval = 0.53, 0.94, P for trend = 0.02). The study, which preceded the establishment of palliative care programs, suggests that care given to ovarian cancer patients at the end of life may be inadequate.",
keywords = "cohort study, complications, death, electronic medical records, end of life, medical record abstraction, Ovarian cancer",
author = "Herrinton, {Lisa J.} and Christine Neslund-Dudas and Rolnick, {Sharon J.} and Hornbrook, {Mark C.} and Bachman, {Donald J.} and Darbinian, {Jeanne A.} and Jackson, {Jody M.} and Coughlin, {Steven Scott}",
year = "2007",
month = "9",
day = "1",
doi = "10.1016/j.jpainsymman.2006.11.011",
language = "English (US)",
volume = "34",
pages = "237--243",
journal = "Journal of Pain and Symptom Management",
issn = "0885-3924",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Complications at the End of Life in Ovarian Cancer

AU - Herrinton, Lisa J.

AU - Neslund-Dudas, Christine

AU - Rolnick, Sharon J.

AU - Hornbrook, Mark C.

AU - Bachman, Donald J.

AU - Darbinian, Jeanne A.

AU - Jackson, Jody M.

AU - Coughlin, Steven Scott

PY - 2007/9/1

Y1 - 2007/9/1

N2 - Women dying of ovarian cancer vary considerably in their complications and in the types of health care they receive. The objective of this study was to describe the complications of ovarian cancer, other than pain, and their treatment at the end of life. This study used a cohort of 421 enrollees in three nonprofit managed-care organizations who died with ovarian cancer during 1995-2000. Data were collected from abstraction of paper and electronic medical records. Proportions of women experiencing complications and undergoing treatments were calculated. Logistic regression was used to evaluate the association of patient characteristics with the probability of receiving an intervention for complications. The most common complications recorded in the medical record were fatigue or weakness (75%), nausea or vomiting (71%), constipation (49%), edema of the extremities (44%), and anemia (34%). The prevalence of major complications was as follows: ascites, 28%; bowel obstruction, 12%; pleural effusion, 10%; bladder obstruction, 3%; and disordered nutrition that required support with parenteral nutrition, 9%. Patients may not always have received interventions for major complications; for example, pleural effusion apparently was left untreated in almost half of the women with this problem. After adjustment, women who died at younger ages were more likely to receive an intervention, compared to older women (odds ratio for each decade of age, 0.71, 95% confidence interval = 0.53, 0.94, P for trend = 0.02). The study, which preceded the establishment of palliative care programs, suggests that care given to ovarian cancer patients at the end of life may be inadequate.

AB - Women dying of ovarian cancer vary considerably in their complications and in the types of health care they receive. The objective of this study was to describe the complications of ovarian cancer, other than pain, and their treatment at the end of life. This study used a cohort of 421 enrollees in three nonprofit managed-care organizations who died with ovarian cancer during 1995-2000. Data were collected from abstraction of paper and electronic medical records. Proportions of women experiencing complications and undergoing treatments were calculated. Logistic regression was used to evaluate the association of patient characteristics with the probability of receiving an intervention for complications. The most common complications recorded in the medical record were fatigue or weakness (75%), nausea or vomiting (71%), constipation (49%), edema of the extremities (44%), and anemia (34%). The prevalence of major complications was as follows: ascites, 28%; bowel obstruction, 12%; pleural effusion, 10%; bladder obstruction, 3%; and disordered nutrition that required support with parenteral nutrition, 9%. Patients may not always have received interventions for major complications; for example, pleural effusion apparently was left untreated in almost half of the women with this problem. After adjustment, women who died at younger ages were more likely to receive an intervention, compared to older women (odds ratio for each decade of age, 0.71, 95% confidence interval = 0.53, 0.94, P for trend = 0.02). The study, which preceded the establishment of palliative care programs, suggests that care given to ovarian cancer patients at the end of life may be inadequate.

KW - cohort study

KW - complications

KW - death

KW - electronic medical records

KW - end of life

KW - medical record abstraction

KW - Ovarian cancer

UR - http://www.scopus.com/inward/record.url?scp=34548504301&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548504301&partnerID=8YFLogxK

U2 - 10.1016/j.jpainsymman.2006.11.011

DO - 10.1016/j.jpainsymman.2006.11.011

M3 - Article

C2 - 17606360

AN - SCOPUS:34548504301

VL - 34

SP - 237

EP - 243

JO - Journal of Pain and Symptom Management

JF - Journal of Pain and Symptom Management

SN - 0885-3924

IS - 3

ER -